UNSPSC 51172172: Fenpipramide hydrochloride

This classification denotes an antimuscarinic agent with the molecular formula C21H26N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KJ2V75P034, chemically known as alpha,alpha-diphenylpiperidine-1-butyramide monohydrochloride but more generally known as fenpipramide hydrochloride, which bears US NIH Compound Identifier 166974. European Medicines Agency schedules Fenpipramide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02123MIG.

Most nations, for tariff and trade purposes, schedule fenpipramide hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, FENPIPRAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Fenpipramide hydrochloride bears US NLM NCI C78073. SMILES: C1CCC(CC1)C(CCN2CCCCC2)(C3CCCCC3)C(=O)N.CL.

UNSPSC 51172172 Fenpipramide hydrochloride is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity posted under this code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—does not involve fenpipramide hydrochloride or pharmaceutical procurement at all. The scope encompasses staffing two collection sites in Plano and McKinney, operating an Interactive Voice Response system for randomized testing notifications, and conducting immunoassay screening with LC/MS/MS or GC/MS confirmation on approximately 25,031 tests annually, including five-panel and six-panel drug screens with oral fluid and hair testing alternatives. The vendor must maintain lab certification from SAMHSA, TX DPS, or CAP. This is a lab services and staffing contract, not a chemical or pharmaceutical supply procurement, suggesting the code may have been misapplied to the opportunity.

Collin County Community Supervision and Corrections Department is the sole recent issuing body identified under this code. The RFP, posted September 25, 2026, carries a response deadline of July 23, 2026 (a discrepancy in the source data), an estimated contract value of $600,000, and a two-year initial term commencing September 1, 2026, with three optional one-year renewals. Pricing is submitted on a per-test basis with three service models (screening only, confirmation after screening, or screening with automatic confirmation of positives), and all costs must include freight, delivery, insurance, and staffing with no additional surcharges. The anticipated award date is August 10, 2026. Evaluation weighs vendor understanding and firm qualifications at 30 and 25 points respectively, client references at 15 points, cost at 30 points, and optional Phase 2 demonstrations and interviews at up to 30 points. The contract is funded by the Texas Department of Criminal Justice-Community Justice Assistance Division, subject to annual availability.